Version 5.4
Bos taurus Protein: PADI3
Summary
InnateDB Protein IDBP-698556.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PADI3
Protein Name peptidyl arginine deiminase, type III
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000015978
InnateDB Gene IDBG-645801 (PADI3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004668 protein-arginine deiminase activity
GO:0005509 calcium ion binding
Biological Process
GO:0006464 cellular protein modification process
GO:0018101 protein citrullination
Cellular Component
GO:0005737 cytoplasm
Protein Structure and Domains
PDB ID
InterPro IPR008972 Cupredoxin
IPR013530 Protein-arginine deiminase, C-terminal
IPR013732 Protein-arginine deiminase (PAD) N-terminal
IPR013733 Protein-arginine deiminase (PAD), central domain
IPR016296 Protein-arginine deiminase, subgroup
PFAM PF03068
PF08526
PF08527
PRINTS
PIRSF PIRSF001247
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BD46
UniProt Splice Variant
Entrez Gene 508160
UniGene Bt.112133
RefSeq XP_003581954
HUGO HGNC:18337
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02006575
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca